TUMOR-NECROSIS-FACTOR INDUCES E-SELECTIN PRODUCTION IN SPLANCHNIC ARTERY-OCCLUSION SHOCK

被引:10
|
作者
ALTAVILLA, D [1 ]
SQUADRITO, F [1 ]
CANALE, P [1 ]
IOCULANO, M [1 ]
CAMPO, GM [1 ]
SQUADRITO, G [1 ]
SAITTA, A [1 ]
CAPUTI, AP [1 ]
机构
[1] UNIV MESSINA, SCH MED, DEPT INTERNAL MED, I-98122 MESSINA, ITALY
关键词
LEUKOCYTE ACCUMULATION; CLORICROMENE;
D O I
10.1152/ajpheart.1995.268.4.H1412
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Splanchnic arteries were clamped for 45 min to induce splanchnic artery occlusion (SAO) shock in anesthetized rats. Sham-operated animals were used as controls. Survival time, serum tumor necrosis factor-alpha (TNF-alpha), white blood cell (WBC) count, mean arterial blood pressure, myeloperoxidase (MPO) activity, and serum levels of soluble E-selectin (sE-selectin) were investigated. SAG-shocked rats exhibited decreased survival time (95 +/- 11 min, whereas sham-shocked rats survived for > 5 h), reduced mean arterial blood pressure, increased serum levels of TNF-alpha (185 +/- 8 U/ml) and MPO activity in the ileum (0.11 +/- 0.03 U x 10(-3)/g tissue) and lung (1.5 +/- 0.4 U x 10(-3)/g tissue), leukopenia, and enhanced serum levels of sE-selectin. Furthermore SAG-shocked rats showed histological alterations in the ileum and lung. Administration of cloricromene (2 mg/kg iv), an inhibitor of TNF-alpha, significantly increased survival time (225 +/- 10 min), decreased serum levels of TNF-alpha and sE-selectin, reduced leukopenia and MPO activity in the ileum (0.035 +/- 0.003 U x 10(-3)/g tissue) and lung (0.3 +/- 0.005 U x 10(-3)/g tissue), improved the cardiovascular changes, and reduced the histological changes in the ileum and lung. Finally, an anti-E-selectin antibody protected rats against SAO shock. Our findings are consistent with an involvement of E-selectin, ''in vivo,'' in the pathogenesis of SAO shock.
引用
收藏
页码:H1412 / H1417
页数:6
相关论文
共 50 条
  • [21] PHARMACOLOGICAL AMELIORATION OF SPLANCHNIC ARTERY-OCCLUSION SHOCK USING HYDROXYETHYL STARCH
    SIMONIAN, GT
    DARDIK, H
    HALLAC, D
    IBRAHIM, I
    CLINICAL RESEARCH, 1991, 39 (04): : A800 - A800
  • [22] SOLUBLE E-SELECTIN AND SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR (60-KD) SERUM LEVELS IN PATIENTS WITH PSORIASIS
    BONIFATI, C
    TRENTO, E
    CARDUCCI, M
    SACERDOTI, G
    MUSSI, A
    FAZIO, M
    AMEGLIO, F
    DERMATOLOGY, 1995, 190 (02) : 128 - 131
  • [23] INCREASED INOTROPIC STATE DURING SPLANCHNIC ARTERY-OCCLUSION SHOCK IN THE DOG
    KOBER, PM
    GIBBONS, DA
    RAYMOND, RM
    CIRCULATORY SHOCK, 1987, 21 (02) : 97 - 110
  • [24] CARDIAC-PERFORMANCE IN SPLANCHNIC ARTERY-OCCLUSION SHOCK - EFFECT OF DEXAMETHASONE
    GOLDFARB, RD
    GLENN, TM
    URSCHEL, CW
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 297 - 297
  • [25] PENTOXIFYLLINE INHIBITS TUMOR-NECROSIS-FACTOR PRODUCTION IN SEPTIC SHOCK
    MATUSCHAK, GM
    LAMPRECH, KE
    LECHNER, AJ
    JOURNAL OF INTERFERON RESEARCH, 1994, 14 (05): : 293 - 295
  • [26] TUMOR-NECROSIS-FACTOR AND SEPTIC SHOCK
    BAUD, L
    CADRANEL, J
    OFFENSTADT, G
    LUQUEL, L
    GUIDET, B
    AMSTUTZ, P
    CRITICAL CARE MEDICINE, 1990, 18 (03) : 349 - 350
  • [27] ADRENAL AND INTESTINAL SECRETION OF CATECHOLAMINES AND NEUROPEPTIDES DURING SPLANCHNIC ARTERY-OCCLUSION SHOCK
    GAUMANN, DM
    YAKSH, TL
    CIRCULATORY SHOCK, 1988, 26 (04) : 391 - 407
  • [28] ACUTE EFFECTS OF UNSATURATED FATTY-ACIDS IN SPLANCHNIC ARTERY-OCCLUSION SHOCK
    AOKI, N
    SIEGFRIED, M
    TSAO, P
    LEFER, AM
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 1989, 37 (02): : 89 - 95
  • [29] BENEFICIAL MECHANISMS OF ACTION OF A PROSTACYCLIN ENHANCING AGENT IN SPLANCHNIC ARTERY-OCCLUSION SHOCK
    AOKI, N
    SIEGFRIED, M
    TSAO, P
    LENTO, P
    LEFER, AM
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1988, 60 (03): : 275 - 289
  • [30] RELEASE OF TUMOR-NECROSIS-FACTOR AFTER PULMONARY-ARTERY OCCLUSION AND REPERFUSION
    PALACE, GP
    DELVECCHIO, PJ
    HORGAN, MJ
    MALIK, AB
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (01): : 143 - 147